ClinVar Miner

Submissions for variant NM_004281.3(BAG3):c.468_470GGC[4] (p.Ala160dup) (rs139438727)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics Inc RCV000587453 SCV000841020 benign not provided 2018-08-09 criteria provided, single submitter clinical testing
EGL Genetic Diagnostics,Eurofins Clinical Diagnostics RCV000037895 SCV000227329 benign not specified 2014-12-16 criteria provided, single submitter clinical testing
GeneDx RCV000037895 SCV000235737 benign not specified 2014-05-01 criteria provided, single submitter clinical testing The variant is found in CARDIOMYOPATHY panel(s).
Illumina Clinical Services Laboratory,Illumina RCV000261469 SCV000360566 likely benign Dilated Cardiomyopathy, Dominant 2016-06-14 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV000318585 SCV000360567 likely benign Myofibrillar Myopathy, Dominant 2016-06-14 criteria provided, single submitter clinical testing
Integrated Genetics/Laboratory Corporation of America RCV000587453 SCV000698280 benign not provided 2017-08-16 criteria provided, single submitter clinical testing Variant summary: The BAG3 c.474_476dupGGC (p.Ala158dup) variant (alternatively also known as c.465_466insGCG) leads to in-frame insertion of one alanine residue in a stretch of six alanine residues in exon 2. Mutation taster predicts a benign outcome for this variant. This variant was found in 241/115882 control chromosomes (3 homozygotes) from ExAC, predominantly observed in the African subpopulation at a frequency of 0.025248 (234/9268). This frequency is about 646 times the estimated maximal expected allele frequency of a pathogenic BAG3 variant (0.0000391), suggesting this is likely a benign polymorphism found primarily in the populations of African origin. In addition, multiple clinical diagnostic laboratories/reputable databases in ClinVar have classified this variant as benign. To our knowledge, this variant t has not been reported in affected individuals via publications, nor has it been evaluated for functional impact by in vivo/vitro studies. Taken together, this variant is classified as benign.
Invitae RCV000229509 SCV000288305 benign Myofibrillar myopathy, BAG3-related; Dilated cardiomyopathy 1HH 2018-01-04 criteria provided, single submitter clinical testing
Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine RCV000037895 SCV000061557 benign not specified 2012-11-19 criteria provided, single submitter clinical testing Ala160_Gln161insAla in exon 2 of BAG3: This variant adds fourth copy to a string of 3 consecutive GGC repeats, which results in the insertion of an alanine (Ala ) residue in a string of 6 alanines. This variant is not expected to have clinic al significance because it has been identified in 2.8% (117/4168) of African Ame rican chromosomes from a broad population by the NHLBI Exome Sequencing Project (; dbSNP rs139438727).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.